Logos Global Management LP 13D and 13G filings for Design Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-13 6:53 pm Purchase | 2024-08-09 | 13D | Design Therapeutics, Inc. DSGN | Logos Global Management LP | 4,232,627 7.500% | 1,420,126 (+50.49%) | Filing |
| 2022-03-31 4:23 pm Purchase | 2022-03-21 | 13D | Design Therapeutics, Inc. DSGN | Logos Global Management LP | 2,812,501 5.000% | 2,812,501 (New Position) | Filing |